Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kilitch Drugs (India) Limited ( (IN:KILITCH) ) has shared an announcement.
Kilitch Drugs (India) Limited has announced the details of its 33rd Annual General Meeting (AGM) through a newspaper publication. The AGM will address key corporate matters such as book closure, e-voting, and the availability of the Annual Report for the financial year 2024-25 on the company’s website and stock exchanges. This announcement is part of the company’s compliance with SEBI regulations, ensuring transparency and accessibility for its stakeholders.
More about Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited operates in the pharmaceutical industry, focusing on the manufacturing and distribution of pharmaceutical products. The company is involved in the production of a wide range of drugs and has a market focus on both domestic and international markets.
Average Trading Volume: 2,470
Technical Sentiment Signal: Hold
Current Market Cap: 6.21B INR
See more data about KILITCH stock on TipRanks’ Stock Analysis page.